Human papillomavirus vaccine delivery strategiW;Stratégies de délivrance du vaccin contre le papillomavirus humain ayant réalisé une forte couverture vaccinale dans des pays à revenu faible et moyen

Bulletin of the World Health Organization

Volumn 89, Issue 11, 2011, Pages 821-830

  Scott LaMontagne, D ^a   Barge, Sandhya ^b   Le, Nga Thi ^a   Mugisha, Emmanuel ^a   Penny, Mary E ^c   Gandhi, Sanjay ^a   Janmohamed, Amynah ^d   Kumakech, Edward ^a   Rocio Mosqueira, N ^c   Nguyen, Nghi Quy ^e   Paul, Proma ^a   Tang, Yuxiao ^a   Minh, Tran Hung ^f   Uttekar, Bella Patel ^b   Jumaan, Aisha O ^g  

^a PATH   (United States)

^b Centre for Operations Research and Training   (India)

^c INSTITUTO DE INVESTIGACIÓN NUTRICIONAL   (Peru)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e WORLD BANK   (United States)

^f Consultation of Investment in Health Promotion ^*  (Viet Nam)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER; DEVELOPING WORLD; DISEASE CONTROL; VACCINATION; VACCINE; VIRUS;

ABSENTEEISM; ADOLESCENT; ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DEVELOPING COUNTRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH CENTER; HEALTH EDUCATION; HEALTH PROMOTION; HEALTH SURVEY; HOUSEHOLD; HUMAN; INDIA; MOTIVATION; OPEN ENDED QUESTIONNAIRE; PAPILLOMAVIRUS INFECTION; PARENT; PATIENT ATTITUDE; PERU; POPULATION RESEARCH; SCHOOL CHILD; SCHOOL HEALTH SERVICE; TREATMENT REFUSAL; UGANDA; UTERINE CERVIX CANCER; VACCINATION; VIET NAM;

ADOLESCENT; CHILD; CLUSTER ANALYSIS; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; FEMALE; HEALTH CARE SURVEYS; HUMANS; IMMUNIZATION PROGRAMS; INCOME; INDIA; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PERU; POVERTY; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; SOCIOECONOMIC FACTORS; UGANDA; UTERINE CERVICAL NEOPLASMS; VIETNAM; WOMEN'S HEALTH; WORLD HEALTH;

PERU; UGANDA; VIET NAM;

HUMAN PAPILLOMAVIRUS;

EID: 80055108789     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.11.08986     Document Type: Article

References (41)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917. doi:10.1002/ijc.25516 PMID:21351269
2. Wittet S, Tsu V. Cervical cancer prevention and the Millennium Development Goals. Bull World Health Organ 2008;86:488-90. doi:10.2471/BLT.07.050450 PMID:18568279
3. Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix-worldwide. Asian Pac J Cancer Prev 2009;10:645-50. PMID:19827887
4. Brown RE, Breugelmans JG, Theodoratou D, Bénard S. Costs of detection and treatment of cervical cancer, cervical dysplasia and genital warts in the UK. Curr Med Res Opin 2006;22:663-70. doi:10.1185/030079906X99972 PMID:16684427
5. Insinga RP, Dasbach EJ, Elbasha EH. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature. Pharmacoeconomics 2005;23:1107-22. doi:10.2165/00019053-200523110-00004 PMID:16277547
6. State of the world's vaccines and immunization. 3rd ed. Geneva: World Health Organization; 2009.
7. Lim SS, Stein DB, Charrow A, Murray CJ. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage. Lancet 2008;372:2031-46. doi:10.1016/S0140-6736(08)61869-3 PMID:19070738
8. Centers for Disease Control and Prevention. Global routine vaccination coverage, 2009. MMWR Morb Mortal Wkly Rep 2010;59:1367-71. PMID:21030941
9. Luciani S, Jauregui B, Kieny C, Andrus JK. Human papillomavirus vaccines: new tools for accelerating cervical cancer prevention in developing countries. Immunotherapy 2009;1:795-807. doi:10.2217/imt.09.48 PMID:20636024
10. Goldie SJ, O'Shea M, Campos NG, Diaz M, Sweet S, Kim SY. Health and exonomic outcomes of HPV 16, 18 vaccination in 72 GAVI-eligible countries. Vaccine 2008;26:4080-93. doi:10.1016/j.vaccine.2008.04.053 PMID:18550229
11. World Health Organization. Human papillomavirus vaccines, WHO position paper. Wkly Epidemiol Rec 2009;15:117-32.
12. GAVI welcomes lower prices for life-saving vaccines. Geneva: GAVI Alliance; 2011. Available from: http://www.gavialliance.org/library/news/press-releases/2011/gavi-welcomes-lower-prices-for-life-saving-vaccines/ [accessed 8 August 2011].
13. Bingham A, Janmohamed A, Bartolini R, Creed-Kanashiro HM, Katahoire AR, Khan I etal. An approach to formative research in HPV vaccine introduction planning in low-resource settings. Open Vaccine J 2009;2:1-16. doi:10.2174/1875035400902010001
14. Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, Siu G etal. An assessment of the readiness for introduction of the HPV vaccine in Uganda. Afr J Reprod Health 2008;12:159-72. PMID:19435020
15. Bartolini RM, Drake JK, Creed-Kanashiro HM, Díaz-Otoya MM, Mosqueira-Lovón NR, Penny ME etal. Formative research to shape HPV vaccine introduction strategies in Peru. Salud Publica Mex 2010;52:226-33. doi:10.1590/S0036-36342010000300007 PMID:20485886
16. Nghi NQ, LaMontagne DS, Bingham A, Rafiq M, Phuong Mai LT, Phuong Lien NT etal. Human papillomavirus vaccine introduction in Vietnam: formative research findings. Sex Health 2010;7:262-70. doi:10.1071/SH09123 PMID:20719213
17. Jacob M, Mawar N, Menezes L, Kaipilyawar S, Gandhi S, Khan I etal. Assessing the environment for introduction of human papillomavirus vaccine in India. Open Vaccine J 2010;3:96-107. doi:10.2174/1875035401003010096
18. Penny M, Bartolini R, Mosqueira NR, Lamontagne DS, Mendoza MA, Ramos I etal. Strategies to vaccinate against cancer of the cervix: feasibility of a school-based HPV vaccination program in Peru. Vaccine 2011;29:5022-30. doi:10.1016/j.vaccine.2011.04.078 PMID:21609748
19. Microplanning for immunization service delivery using the reaching every district (RED) strategy. Geneva: World Health Organization, Department of Immunization, Vaccines and Biologicals; 2009.
20. Vaccine introduction guidelines: adding a vaccine to a national immunization program-decision and implementation (WHO/IVB/05.18). Geneva: World Health Organization, Department of Immunization, Vaccines and Biologicals; 2005.
21. Immunization coverage cluster survey-reference manual (WHO/IVB/04.23). Geneva: World Health Organization, Department of Immunization, Vaccines and Biologicals; 2005.
22. Module 7. The EPI coverage survey: training for mid-level managers (MLM). Geneva: World Health Organization, Department of Immunization, Vaccines and Biologicals; 2008.
23. Preparing for the introduction of HPV vaccines: policy and programme guidance for countries. Geneva: World Health Organization, Department of Reproductive Health and Research; 2006.
24. Kaufmann AM, Schneider A. New paradigm for prevention of cervical cancer. Eur J Obstet Gynecol Reprod Biol 2007;130:25-9. doi:10.1016/j.ejogrb.2006.07.048 PMID:16973254
25. Brabin L, Greenberg DP, Hessel L, Hyer R, Ivanoff B, Van Damme P. Current issues in adolescent immunization. Vaccine 2008;26:4120-34. doi:10.1016/j.vaccine.2008.04.055 PMID:18617295
26. Das BC, Hussain S, Nasare V, Bharadwaj M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine 2008;26:2669-79. doi:10.1016/j.vaccine.2008.03.056 PMID:18455843
27. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M etal. A population-based evaluation of a publicly-funded school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 2010;7:e1000270. doi:10.1371/journal.pmed.1000270 PMID:20454567
28. Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H etal. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008;336:1056-8. doi:10.1136/bmj.39541.534109.BE PMID:18436917
29. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2008. MMWR Morb Mortal Wkly Rep 2010;59:1018-23. PMID:20724968
30. Watson M, Shaw D, Molchanoff L, McInnes C. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia. Aust N Z J Public Health 2009;33:365-70. doi:10.1111/j.1753-6405.2009.00409.x PMID:19689598
31. Human papillomavirus and HPV vaccines: technical information for policy-makers and health professionals. Geneva: World Health Organization, Department of Immunization, Vaccines and Biologicals; 2007.
32. Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M etal. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010;28:4027-37. doi:10.1016/j.vaccine.2010.03.063 PMID:20412875
33. Madhivanan P, Krupp K, Yashodha MN, Marlow L, Klausner JD, Reingold AL. Attitudes toward HPV vaccination among parents of adolescent girls in Mysore, India. Vaccine 2009;27:5203-8. doi:10.1016/j.vaccine.2009.06.073 PMID:19596420
34. Becker-Dreps S, Otieno WA, Brewer NT, Agot K, Smith JS. HPV vaccine acceptability among Kenyan women. Vaccine 2010;28:4864-7. doi:10.1016/j.vaccine.2010.05.034 PMID:20566394
35. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Chapter 24: Psychological aspects of vaccine acceptability. Vaccine 2006;24(Suppl. 3):S201-9. doi:10.1016/j.vaccine.2006.06.017
36. Lenselink CH, Gerrits MJ, Massuger L, van Hamont D, Bekkers R. Parental acceptance of human papillomavirus vaccines. Eur J Obstet Gynecol Reprod Biol 2008;137:103-7. doi:10.1016/j.ejogrb.2007.02.012 PMID:17368910
37. Leader AE, Weiner JL, Kelly BJ, Hornik RC, Cappella JN. Effects of information framing on human papillomavirus vaccination. J Womens Health (Larchmt) 2009;18:225-33. doi:10.1089/jwh.2007.0711 PMID:19183094
38. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005;159:132-7. doi:10.1001/archpedi.159.2.132 PMID:15699306
39. Bharadwaj M, Hussain S, Nasare V, Das BC. HPV & HPV vaccination: issues in developing countries. Indian J Med Res 2009;130:327-33. PMID:19901442
40. Ferris DG, Cromwell L, Waller JL, Horn L. Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children. J Low Genit Tract Dis 2010;14:179-84. doi:10.1097/LGT.0b013e3181d41806 PMID:20592552
41. Ministerio de Salud. Peru. Resolución Ministerial No. 070-2011. El peruano. 2011 2 February. Spanish. Available from: http://www.tvperu.gob.pe/noticias/politica/presidente/18244-presidente-lanza-campana-de-vacunacion.html [accessed 24 August 2011].